Description
PRINCIPIO ACTIVO: TERBINAFINA CLORHIDRATO
FORMA FARMACÉUTICA: 24 GRAGEAS
FORMA FARMACÉUTICA: 1 AEROSOL
DOSIS: 900 G
Prevención de eventos aterotrombóticos en pacientes con enfermedad coronaria crónica
SIFROL 0 5MG TAB C30 VITACILINA PRINCIPIO ACTIVO: TERBINAFINA CLORHIDRATOPRINCIPIO ACTIVO: PRAMIPEXOL DIHIDROCLORURO DOSIS: 0. 5 MG FORMA FARMACUTICA: 30 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
